☆ 4.6 Letter

Response to erythropoiesis-stimulating agents in patients with WHO-defined myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T)

BRITISH JOURNAL OF HAEMATOLOGY (2020)

Get Full Text
Add to Collection

Journal

BRITISH JOURNAL OF HAEMATOLOGY
Volume 189, Issue 3, Pages E104-E108

Publisher

WILEY
DOI: 10.1111/bjh.16515

Keywords

MDS; MPN-RS-T; myeloid leukaemia; erythropoiesis stimulating agents; ESA; MDS-RS; sideroblastic anaemia

Categories

Hematology

Funding

  1. Henry J. Predolin Foundation for Research in Leukemia, Mayo Clinic, Rochester, MN, USA
  2. Conquer Cancer Foundation (CCF) of American Society of Clinical Oncology (ASCO)

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.